Search Results - "Marcu, Loredana"

Refine Results
  1. 1

    Developments on tumour site-specific chrono-oncology towards personalised treatment by Marcu, Loredana G.

    Published in Critical reviews in oncology/hematology (01-11-2022)
    “…Research into chronotherapy has seen notable developments over the past decades, with a clear focus on the identification of circadian clock genes as potential…”
    Get full text
    Journal Article
  2. 2

    Circadian rhythm-based cancer therapy in randomised clinical trials by Marcu, Loredana G

    “…Since the 2017 Nobel Prize awarded to J. Hall, M. Rosbash and M.W. Young for their discoveries of molecular mechanisms behind the biological clock, circadian…”
    Get full text
    Journal Article
  3. 3

    Correlations between patient-specific parameters and dosimetric indices for personalized breast cancer radiotherapy by Costin, Ioana-Claudia, Marcu, Loredana G.

    Published in Scientific reports (30-10-2024)
    “…Treatment planning parameters in radiotherapy are key elements that dictate the success of treatment outcome. While some parameters are commonly evaluated…”
    Get full text
    Journal Article
  4. 4

    How much is too much? Systematic review of cumulative doses from radiological imaging and the risk of cancer in children and young adults by Marcu, Loredana G., Chau, Minh, Bezak, Eva

    Published in Critical reviews in oncology/hematology (01-04-2021)
    “…[Display omitted] •Literature on risks of cancer following paediatric/young adult imaging was reviewed.•Cancer risks post chest CT exposure decrease with…”
    Get full text
    Journal Article
  5. 5

    Gender and Sex-Related Differences in Normal Tissue Effects Induced by Platinum Compounds by Marcu, Loredana G

    Published in Pharmaceuticals (Basel, Switzerland) (20-02-2022)
    “…Gender medicine in the field of oncology is an under-researched area, despite the existing evidence towards gender-dependent response to therapy and…”
    Get full text
    Journal Article
  6. 6

    Global comparison of targeted alpha vs targeted beta therapy for cancer: In vitro, in vivo and clinical trials by Marcu, Loredana, Bezak, Eva, Allen, Barry J.

    Published in Critical reviews in oncology/hematology (01-03-2018)
    “…•Disseminated disease is the primary cause of cancer death.•Targeted cancer therapy is successful in the management of many intractable cancers.•Short ranged,…”
    Get full text
    Journal Article
  7. 7

    Cannot Target What Cannot Be Seen: Molecular Imaging of Cancer Stem Cells by Marcu, Loredana G, Moghaddasi, Leyla, Bezak, Eva

    “…Cancer stem cells are known to play a key role in tumour development, proliferation, and metastases. Their unique properties confer resistance to therapy,…”
    Get full text
    Journal Article
  8. 8

    Gender-dependent radiotherapy: The next step in personalised medicine? by De Courcy, Louis, Bezak, Eva, Marcu, Loredana G.

    Published in Critical reviews in oncology/hematology (01-03-2020)
    “…•Research shows small but significant difference in radiation response between sexes.•Difference in inflammatory response, polymorphism, oestrogen are few…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Qualitative and quantitative evaluation of the role of CBCT in rectal cancer radiotherapy by Catona, Geanina-Mirela, Marcu, Loredana G.

    Published in Radiologia medica (21-11-2024)
    “…Verifying patients' position and internal anatomical changes are important steps in the radiotherapy of rectal cancer. Cone Beam Computed Tomography (CBCT) is…”
    Get full text
    Journal Article
  11. 11

    Radiobiological and Treatment-Related Aspects of Spatially Fractionated Radiotherapy by Moghaddasi, Leyla, Reid, Paul, Bezak, Eva, Marcu, Loredana G

    “…The continuously evolving field of radiotherapy aims to devise and implement techniques that allow for greater tumour control and better sparing of critical…”
    Get full text
    Journal Article
  12. 12

    The Promise of Novel Biomarkers for Head and Neck Cancer from an Imaging Perspective by Marcu, Loredana G, Reid, Paul, Bezak, Eva

    “…It is an agreed fact that overall survival among head and neck cancer patients has increased over the last decade. Several factors however, are still held…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Cardio-oncology concerns in radiotherapy: Heart and cardiac substructure toxicities from modern delivery techniques by Costin, Ioana-Claudia, Cinezan, Corina, Marcu, Loredana G.

    Published in Critical reviews in oncology/hematology (01-12-2024)
    “…Cardio-oncology is lately gaining more attention due to radiation-induced cardiac events reported by a very large number of studies. In view of this, the…”
    Get full text
    Journal Article
  15. 15

    Future treatment directions for HPV-associated head and neck cancer based on radiobiological rationale and current clinical evidence by Marcu, Loredana G

    Published in Critical reviews in oncology/hematology (01-07-2016)
    “…Highlights • HPV status is a new variable in the equation of head and neck cancer treatment. • HPV+ oropharyngeal cancer exhibits different biological…”
    Get full text
    Journal Article
  16. 16

    Opportunities in Cancer Therapies: Deciphering the Role of Cancer Stem Cells in Tumour Repopulation by Marcu, Loredana G, Dell'Oro, Mikaela, Bezak, Eva

    “…Tumour repopulation during treatment is a well acknowledged yet still challenging aspect of cancer management. The latest research results show clear evidence…”
    Get full text
    Journal Article
  17. 17

    Is there a dosimetric advantage of volumetric modulated arc therapy over intensity modulated radiotherapy in head and neck cancer? by Buciuman, Nikolett, Marcu, Loredana G.

    Published in European archives of oto-rhino-laryngology (01-11-2022)
    “…Objective A planning study was performed to evaluate dosimetric differences between intensity modulated radiation therapy (IMRT) and volumetric modulated arc…”
    Get full text
    Journal Article
  18. 18

    Patient and treatment-related factors that influence dose to heart and heart substructures in left-sided breast cancer radiotherapy by Costin, Ioana-Claudia, Marcu, Loredana G.

    Published in Physica medica (01-12-2024)
    “…[Display omitted] •Heart and cardiac substructure dosimetry are essential in left-sided breast cancer.•The number of beams used for treatment planning impacts…”
    Get full text
    Journal Article
  19. 19

    The role of hypofractionated radiotherapy in the management of head and neck cancer – a modelling approach by Marcu, Loredana G., Marcu, David

    Published in Journal of theoretical biology (07-12-2019)
    “…•The role of hypofractionated radiotherapy for head & neck cancer is not elucidated.•In silico modelling can assist to identify gaps in research.•Hypoxic and…”
    Get full text
    Journal Article
  20. 20

    Dosimetric evaluation of intensity modulated photon versus proton reirradiation of head and neck cancer by Buciuman, Nikolett, Dasu, Alexandru, Marcu, Loredana G.

    Published in Physica medica (01-07-2024)
    “…•Reirradiation of head & neck cancer is challenging irrespective of radiation quality.•A dosimetric pilot study was conducted on proton vs photon…”
    Get full text
    Journal Article